Generally Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners

Frist:18 Oct 2028, 12:00 GMT-4

Ausschreibungsinformationen

SAM.gov

ABERDEEN PROVING GROU, United States

Art: Special Notice
Verfahren: Special Notice
Referenznummer: 3682a79a97e34c87a3f3a589524aaeaa
NAICS: 541715

W911SR-25-S-GUIDE Notice Type: Special Announcement Synopsis: This is a solicitation for parties interested in participating in projects sought by the The Joint Project Lead Chemical, Biological, Radiological, and Nuclea…

r Defense Enabling Biotechnologies (JPL-CBRND-EB) (JPL EB). JPL EB has the mission to accelerate the delivery of medical countermeasures to the warfighter through the development and implementation of platform systems. Generally Unconstrained Intelligence Drug Engineering (GUIDE) is an integrated co

mputational and experimental platform designed to accelerate medical countermeasure development. GUIDE harnesses the power of advanced simulation and machine learning to enable preparedness and facilitate rapid response to protect the warfi

Alle Ausschreibungsinformationen anzeigen

Dokumente

Alle wichtigen Termine anzeigen